Biliary Interventional Radiology Devices Market Size

  • Report ID: 3162
  • Published Date: Jul 14, 2025
  • Report Format: PDF, PPT

Biliary Interventional Radiology Devices Market Outlook:

Biliary Interventional Radiology Devices Market size was valued at USD 455.2 million in 2024 and is projected to reach USD 742.7 million by the end of 2034, rising at a CAGR of 5.3% during the forecast period, 2025-2034. In 2025, the industry size of biliary interventional radiology devices is estimated at USD 480.2 million.

The reimbursement data for Medicare in the U.S. shows that procedures associated with biliary interventional radiology have undergone adjustments in costs. There has been a reported mean decrease of USD 21.3 per procedure related to the biliary interventional radiology, showing modest downward pressure. Likewise, CPI and PPI figures for supplies and equipment are embedded within broader healthcare indices for the equipment. The data published by the National Institutes of Health shows that almost 20.1 million Americans annually suffer from biliary diseases. The data shows that the patient pool needing such devices is surging significantly.

The supply chain is vulnerable and faces regulations from stringent regulations on medical devices.  These devices are supposed to clear FDA examinations and are supplemented by precise marking of the labeling of the country. Also, there is a huge investment in research and development for these devices, garnering funding of USD 681 million in 2023. Also, trade dynamics illustrate that the total value of imports of biliary devices in the U.S. is almost USD 1.1 billion. Countries are focusing on supply chain resilience, with the country-wise stockpiling of crucial components surging by 12.1% from 2021.


Biliary-Interventional-Radiology-Devices-Market-Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Biliary Interventional Radiology Devices Market size is projected to witness lucrative growth rate during the forecast period i.e., between 2025-2034.

Rising occurrence of cancer, chronic diseases and increasing elderly population will drive the market growth.

Asia Pacific industry is estimated to hold largest revenue share by 2037, owing to increased spending by governmental and non-governmental agencies on improving healthcare infrastructure in the region.

The major players in the market are GE Healthcare (General Electric Company), Siemens Healthcare GmBH, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, Inc., Esaote S.p.A, Hologic, Inc., Fujifilm Corporation, Samsung Medison, among others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos